Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Related to
Medtronic
Medtronic develops healthcare technology for chronic disease treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
StratifiCare
StratifiCare is a medical device that diagnoses severe dengue.
Sector
Subsector
Keywords
Location
total rounds
total raised
HemoSonics
HemoSonics is a medical device company that brings innovative in vitro diagnostics to market to characterize hemostasis.
Sector
Subsector
Keywords
Location
total rounds
total raised
Eigen
Eigen is a medical device company that improves healthcare through innovative breakthroughs in image-guided disease diagnosis and treatment.
Sector
Subsector
Keywords
Location
QuantuMDx Group
QuantuMDx is a medical devices company developing handheld and portable diagnostic, genomic sequencing, and proteomic platforms.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 16.02.2022. Their latest investor RTW Investments LLC. Their latest round Venture - Series Unknown
RTW Investments LLC
RTW Investments is an innovative health care investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Sectoral Asset Management
Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Horizon Technology Finance
Horizon Technology Finance is a venture lending platform that provides structured debt products to life science and technology companies.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
RTW Investments LLC
RTW Investments is an innovative health care investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
RTW Investments LLC
RTW Investments is an innovative health care investment firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Naveen Yalamanchi
Naveen Yalamanchi is a Member of the Board of Directors at Rocket Pharmaceuticals.
current job
Sectoral Asset Management
Sectoral Asset Management is a specialist in managing global investment portfolios in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Marc Andre Marcotte
Mr. Marcotte joined Sectoral in 2006. He is responsible for overseeing the investment research activities at Sectoral. He is also responsible for the coverage of Medical Technology companies. In September 2013, Mr. Marcotte was nominated a Managing Director of Sectoral Asset Management and participates in the Executive Committee of the firm. Prior to joining Sectoral, he worked at CryoCath Technologies, a company specializing in the development of products to treat cardiovascular diseases, where he was the Director of Quality. Before this, he worked with Medtronic AVE in Vancouver as an engineer on angioplasty catheters and stents. He has over eight years of experience in the development of Medical Devices. Mr. Marcotte graduated from Sherbrooke University in 1997 with a Bachelor of Engineering and completed a Master of Business Administration at HEC Montreal in 2003. He obtained his CFA charter in 2010.
current job
SightLine Partners
SightLine Partners manages venture funds for late stage medical technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Richard G. Patton
Dr. Patton is a board-certified pathologist with more than 35 years of active practice experience. Recognizing the patient safety and financial implications of false positive blood cultures, he has long been interested in exploring opportunities to reduce contamination rates. In 2006, Dr. Patton designed a clinical trial to test the effectiveness of Initial Specimen Diversion Technique (ISDT), an innovation that he conceived earlier in his career. The results of the trial were significantly positive and published in the peer-reviewed Journal of Clinical Microbiology. Dr. Patton’s areas of expertise are Anatomic Pathology, Clinical Pathology, and Cytopathology with sub-specialty expertise in Laboratory Administration. He is the chief pathologist and Medical Director of Clinical Laboratories at UW Medicine/Northwest Hospital & Medical Center, acts as the Washington State Commissioner for the College of American Pathologists Laboratory Accreditation Program, is an Associate Clinical Professor of Pathology at University of Washington, and is a published international thought leader on blood culture contamination.
current job
organization founded
Richard G. Patton
Greg Bullington
Greg Bullington is co-founder and CEO of Magnolia Medical Technologies. He has led all commercial aspects of company development since inception including clinical trial design and execution, peer-reviewed publication, product development, manufacturing, commercial launch and overall intellectual property strategy. To date, Greg has raised $25M in capital to drive the successful growth and development of the company. Greg has extensive experience in the healthcare industry having led product commercialization and strategy engagements for a wide variety of companies in the biotech (novel immunotherapy), healthcare insurance, wellness and enterprise software sectors. Greg began his career in professional services with the Audit & Assurance practice of Deloitte & Touche LLP. He continued his professional development as a management consultant with Lake Partners, a Seattle-based strategy firm. In 2006, Greg founded Forum Ventures, a technology commercialization consultancy focused on accelerating the growth of early and mid-stage technology companies. Over the past 15 years, Greg has led engagements and worked with senior executive teams at over 50 companies ranging from Fortune 100 corporations to venture-backed and early stage startups as a consultant, advisor, and investor. Additionally, Greg has significant intellectual property expertise and is the first named inventor on 28 issued patents as well as over 50 pending US and international patent applications.
current job
organization founded
Greg Bullington
Employee Profiles21
Joseph Bishop
SVP of Operations and Product Development
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range